Author: Laureano, Ana Flávia Santarine; Riboldi, Márcia
Title: The different tests for the diagnosis of COVID-19 - A review in Brazil so far Cord-id: mxh38hwd Document date: 2020_1_1
ID: mxh38hwd
Snippet: SARS-CoV-2 is a novel virus from the coronavirus family that emerged in the end of December 2019 in Wuhan, China. The virus is now widespread and causing the current pandemic of COVID-19, a highly pathogenic viral pneumonia, commonly presented with fever and cough, which frequently lead to lower respiratory tract disease with poor clinical outcomes associated with older age and underlying health conditions. Supportive care for patients is typically the standard protocol because no specific effec
Document: SARS-CoV-2 is a novel virus from the coronavirus family that emerged in the end of December 2019 in Wuhan, China. The virus is now widespread and causing the current pandemic of COVID-19, a highly pathogenic viral pneumonia, commonly presented with fever and cough, which frequently lead to lower respiratory tract disease with poor clinical outcomes associated with older age and underlying health conditions. Supportive care for patients is typically the standard protocol because no specific effective antiviral therapies have been identified so far. The current outbreak is challenging governments and health authorities all over the world. In here we present a comparison among the current diagnostic tools and kits being used to test Brazilian population.
Search related documents:
Co phrase search for related documents- accurate sensitive and acute respiratory infection: 1, 2, 3
- acid amplification test and acute respiratory infection: 1, 2, 3, 4, 5
- acute respiratory infection and long period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory infection and long term immunity: 1, 2, 3, 4, 5, 6, 7
Co phrase search for related documents, hyperlinks ordered by date